Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,600,566
-
Share change
-
+533,087
-
Total reported value
-
$115,305,922
-
Price per share
-
$43.81
-
Number of holders
-
102
-
Value change
-
+$23,169,696
-
Number of buys
-
55
-
Number of sells
-
34
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2021
As of 31 Dec 2021,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,600,566 shares.
The largest 10 holders included
UBS Group AG, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Thrivent Financial for Lutherans, JANE STREET GROUP, LLC, Wharton Business Group, LLC, Wealthcare Advisory Partners LLC, LPL Financial LLC, CITADEL ADVISORS LLC, and ROYAL BANK OF CANADA.
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.